Floatz logo

Alpha Tocopherol

Fibrotic Liver Disease

Bambino Gesù Hospital and Research InstitutemixturePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
89/ 100

Competitive context

27 Active assets in the Fibrotic Liver Disease cohort.

Asset / SponsorPhaseRating
Entecavir
Tanta University
Phase 4BB
Peg-Intron
Beth Israel Deaconess Medical Center
Phase 4BB
COLCHICINUM
Zagazig University
Phase 4BB
Peg-Ifn
Beijing Friendship Hospital
Phase 4BB
A THERAPEUTIC PEGYLATED FIBROBLAST GROWTH FACTOR 21 AGONIST/MIMETIC WHICH RESTORES LEPTIN RESPONSIVENESS
Bristol-Myers Squibb
Phase 2BB

View all 50 →

Same molecule, other indications

Alpha Tocopherol is also rated in:

metabolic dysfunction-associated steatohepatitisDormant
BBB
Indicative ·
73 / 100
View asset →
fatty liver diseaseDormant
BB
Indicative ·
70 / 100
View asset →
ProdromeDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →